Information From Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
Creator
Spurling, Geoffrey K
Mansfield, Peter R
Montgomery, Brett D
Lexchin, Joel
Doust, Jenny
Othman, Noordin
Vitry, Agnes I
Bibliographic Citation
PLoS medicine 2010 October 19; 7(10): e1000352
Abstract
Pharmaceutical companies spent $57.5 billion on pharmaceutical promotion in the United States in 2004. The industry claims that promotion provides scientific and educational information to physicians. While some evidence indicates that promotion may adversely influence prescribing, physicians hold a wide range of views about pharmaceutical promotion. The objective of this review is to examine the relationship between exposure to information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing.
Date
2010-10-19Subject
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Is Australia's National Medicines Policy Failing? The Case of COX-2 Inhibitors
Vitry, Agnes; Lexchin, Joel; Mansfield, Peter R. (2007)